Display options
Cite
Shoja S, Moosavian M, Peymani A, et al. Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran. Iran J Microbiol. 2013;5(4):315-22
Shoja, S., Moosavian, M., Peymani, A., Tabatabaiefar, M. A., Rostami, S., & Ebrahimi, N. (2013). Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran. Iranian journal of microbiology, 5(4), 315-22.
Shoja, Saeed, et al. "Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran." Iranian journal of microbiology vol. 5,4 (2013): 315-22.
Shoja S, Moosavian M, Peymani A, Tabatabaiefar MA, Rostami S, Ebrahimi N. Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran. Iran J Microbiol. 2013 Dec;5(4):315-22. PMID: 25848498; PMCID: PMC4385154.
Copy Download .nbib Format: NLM
Share it on

Iran J Microbiol. 2013 Dec;5(4):315-22.

Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran.

Iranian journal of microbiology

Saeed Shoja, Mojtaba Moosavian, Amir Peymani, Mohammad Amin Tabatabaiefar, Soodabeh Rostami, Nasim Ebrahimi

Affiliations

  1. Department of Microbiology, School of Medicine, Infectious & Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  2. Department of Microbiology, Qazvin University of Medical Sciences, Qazvin, Iran.
  3. Genetic Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

PMID: 25848498 PMCID: PMC4385154

Abstract

BACKGROUND AND OBJECTIVES: Carbapenem resistant A. baumannii is an emerging cause of nosocomial infections. The aims of this study were identification of the most prevalent of carbapenem resistant genes, molecular typing and antimicrobial evaluation of A.baumannii in intensive care units.

MATERIALS AND METHODS: Two hundred and six A. baumannii were isolated from tracheal tube discharge of hospitalized patients at different intensive care units in Ahvaz, Iran. Antimicrobial susceptibility test was done on all isolates. Multiplex and singleplex PCR were performed for detection of bla OXA-23-like, bla OXA-24-like, bla OXA-51-like, bla OXA-58-like, bla VIM, bla IMP, bla SPM and bla NDM genes. Genetic relationship of all isolates was determined by REP-PCR method.

RESULTS: Out of 206 examined isolates, 198 (96.1%) isolates were resistant to imipenem and meropenem. However 3.9% isolates were sensitive to these antibiotics. The bla OXA-23-like and bla OXA-24-like genes were detected in 85% and 8.7% of strains, respectively. No bla OXA-58- like, bla IMP, bla VIM, bla SPM and bla NDM were detected. REP-PCR results showed that isolates were belonged to five genotypes: Genotype A was the most prevalent (P- value < 0.001): it was observed in 75 of 206 strains (36.4%). Genotype B, and C were found in 28.6% and 27.7%, respectively. The rate of other genotypes was as follows: D (2.4%), E (1%).

CONCLUSION: Based on the obtained results, the rate of carbapenem resistance was high among of A. baumannii which was isolated from intensive care units patients and oxacillinase genes were the most prevalent carbapenem resistant genes. These results revealed that three clones, A, B and C of A.baumannii are common in our hospitals.

Keywords: Acinetobacter baumannii; Carbapenem resistant; Intensive Care Units

References

  1. Transplant Proc. 2011 Oct;43(8):3116-20 - PubMed
  2. Int J Antimicrob Agents. 2011 Nov;38(5):403-8 - PubMed
  3. Int J Antimicrob Agents. 2012 Jul;40(1):89-91 - PubMed
  4. Lung India. 2010 Oct;27(4):217-20 - PubMed
  5. J Antimicrob Chemother. 2011 Jan;66(1):54-61 - PubMed
  6. J Clin Microbiol. 1996 May;34(5):1193-202 - PubMed
  7. Int J Antimicrob Agents. 2008 Jan;31(1):50-4 - PubMed
  8. Int J Antimicrob Agents. 2010 Aug;36(2):114-8 - PubMed
  9. Int J Antimicrob Agents. 2010 Mar;35(3):269-73 - PubMed
  10. Int J Antimicrob Agents. 2009 Jul;34(1):25-8 - PubMed
  11. J Hosp Infect. 2011 Jun;78(2):143-8 - PubMed
  12. Diagn Microbiol Infect Dis. 2008 Nov;62(3):326-32 - PubMed
  13. J Infect Dev Ctries. 2009 Jun 01;3(5):335-41 - PubMed
  14. Int J Antimicrob Agents. 2012 Feb;39(2):105-14 - PubMed
  15. Scand J Infect Dis. 2013 Jan;45(1):26-31 - PubMed
  16. Diagn Microbiol Infect Dis. 2011 May;70(1):119-23 - PubMed
  17. Int J Antimicrob Agents. 2006 Apr;27(4):351-3 - PubMed
  18. Int J Antimicrob Agents. 2011 Apr;37(4):302-8 - PubMed
  19. Int J Antimicrob Agents. 2012 Jun;39(6):526-8 - PubMed
  20. J Clin Microbiol. 2002 Dec;40(12):4571-5 - PubMed
  21. Int J Antimicrob Agents. 2008 Jul;32(1):29-32 - PubMed
  22. Int J Infect Dis. 2010 Aug;14(8):e723-9 - PubMed
  23. Int J Antimicrob Agents. 2012 Nov;40(5):398-403 - PubMed
  24. Clin Microbiol Infect. 2000 Dec;6(12):635-43 - PubMed
  25. Euro Surveill. 2012 Feb 16;17(7):null - PubMed
  26. Iran J Microbiol. 2011 Jun;3(2):68-74 - PubMed
  27. Iran J Microbiol. 2011 Dec;3(4):162-9 - PubMed
  28. Jpn J Infect Dis. 2011;64(1):69-71 - PubMed
  29. Intensive Care Med. 2005 May;31(5):649-55 - PubMed
  30. J Antimicrob Chemother. 2010 Oct;65(10):2253-4 - PubMed
  31. Jpn J Infect Dis. 2008 Jul;61(4):274-8 - PubMed

Publication Types